Close Menu

Clostridium difficile

The test is the third in the firm's line of infectious disease assays, which also includes tests for meningococcus and Group B Strep.

The company said it expects a 1 percent increase in 2016 revenues, but noted that the results were adversely affected by certain competitive pressures in Q4, among other problems.

Nearly 8,000 patients participated in a screening study that used a PCR-based detection assay from Becton Dickinson, uncovering a 5 percent carrier rate.

Pages